• Submit to Brain Sciences Login Register
• MDPI
• Journals A-Z
• For Authors
• For Editors
• For Librarians
• About
• Open Access Policy

• Abstract
• Full-Text HTML
• Full-Text PDF [352 KB]
• Full-Text XML
• Article Versions Notes

• Article Statistics
• Google Scholar
• Order Reprints

• Cite this article
• Export to BibTeX
• Export to EndNote

• [+] on DOAJ
• Claycomb, KI.
• Johnson, KM.
• Winokur, PN.
• Sacino, AV.
• Crocker, SJ.
• [+] on Google Scholar
• Claycomb, KI.
• Johnson, KM.
• Winokur, PN.
• Sacino, AV.
• Crocker, SJ.
• [+] on PubMed
• Claycomb, KI.
• Johnson, KM.
• Winokur, PN.
• Sacino, AV.
• Crocker, SJ.

•  CiteULike
•  Facebook
•  Mendeley
•  Twitter
• More services

Open AccessThis article is

• freely available
• re-usable

Brain Sci. 2013, 3(3), 1109-1127; doi:10.3390/brainsci3031109

Review

Astrocyte Regulation of CNS Inflammation and Remyelination

Kumiko I. Claycomb, Kasey M. Johnson, Paige N. Winokur, Anthony V. Sacino and Stephen J. Crocker *

Department of Neuroscience, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA

* Author to whom correspondence should be addressed.

Received: 15 May 2013; in revised form: 12 July 2013 / Accepted: 12 July 2013 / Published: 22 July 2013

(This article belongs to the Special Issue Myelin Repair)

Download PDF Full-Text [352 KB, uploaded 22 July 2013 14:10 CEST]

Abstract: Astrocytes regulate fundamentally important functions to maintain central nervous system (CNS) homeostasis. Altered astrocytic function is now recognized as a primary contributing factor to an increasing number of neurological diseases. In this review, we provide an overview of our rapidly developing understanding of the basal and inflammatory functions of astrocytes as mediators of CNS responsiveness to inflammation and injury. Specifically, we elaborate on ways that astrocytes actively participate in the pathogenesis of demyelinating diseases of the CNS through their immunomodulatory roles as CNS antigen presenting cells, modulators of blood brain barrier function and as a source of chemokines and cytokines. We also outline how changes in the extracellular matrix can modulate astrocytes phenotypically, resulting in dysregulation of astrocytic responses during inflammatory injury. We also relate recent studies describing newly identified roles for astrocytes in leukodystrophies. Finally, we describe recent advances in how adapting this increasing breadth of knowledge on astrocytes has fostered new ways of thinking about human diseases, which offer potential to modulate astrocytic heterogeneity and plasticity towards therapeutic gain. In summary, recent studies have provided improved insight in a wide variety of neuroinflammatory and demyelinating diseases, and future research on astrocyte pathophysiology is expected to provide new perspectives on these diseases, for which new treatment modalities are increasingly necessary.

Keywords: astrocyte; heterogeneity; chemokine; antigen presentation; multiple sclerosis; leukodystrophy; transplantation

Article Statistics

Citations to this Article

Cite This Article